Japan’s Fukushima Medical University and Israel’s Pluristem Therapeutics are to develop Pluristem’s PLX-R18 cells to treat acute radiation syndrome (ARS). Radiation continues to spread following the Fukushima nuclear plant disaster.

http://www.timesofisrael.com/japan-turns-to-israeli-tech-to-treat-radiation-disease/